Latest Headlines

1. Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus 10/23/2026

   Meissner Corporation, a leading manufacturer of advanced microfiltration and therapeutic manufacturing systems for biopharmaceutical production of life-saving and life enhancing medicines, celebrated a double milestone in Athens-Clarke County: the ribbon cutting for its new X-ray irradiation services facility and the groundbreaking for Phase 2 of its Athens, Georgia, U.S.A., manufacturing campus.

2. Revvity Launches Signals LabGistics Solution To Connect And Orchestrate Scientific Workflows 10/21/2026

   Revvity, Inc. (NYSE: RVTY), announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

3. Pharmaceutical Online Covers Honorable Mention FOYA Award Winner, Chugai Pharmaceutical Co., Ltd. 10/13/2026

   Chugai Pharmaceutical Co., Ltd. is advancing pharmaceutical manufacturing through extensive automation at its FJ3 active pharmaceutical ingredient (API) production facility, a project that was recently recognized with a 2026 ISPE Facility of the Year Awards (FOYA) Honorable Mention.

4. Emerson Expands Life Sciences Scheduling Software To Optimize Quality Control Lab Testing 10/13/2026

   Global automation leader Emerson today announced an enhancement to its DeltaV™ Real-Time Scheduling (RTS) software that extends integrated, real-time manufacturing scheduling capabilities to quality control (QC) labs.

5. CDMO Scale-Up Playbook: De-Risking Commercial Supply 10/8/2026

   An aseptic manufacturing CDMO scale-up strategy is the structured plan a sponsor and its manufacturing partner use to move a therapy from late-stage clinical batches to reliable commercial supply while controlling risk, protecting product quality, and ensuring capacity, materials, and processes are ready at the right time.

6. Meissner Introduces The Single-Use Automated Aliquoting System (AAS) 10/5/2026

   Meissner Corporation introduces the Automated Aliquoting System (AAS), a compact, recipe-driven platform that standardizes the transfer of bulk product with high accuracy into final single-use containers of all sizes, automating one of the remaining operator-dependent steps in single-use biomanufacturing.

7. Lonza And Asimov Collaborate To Advance In Vivo Lentiviral Vector Manufacturing 10/5/2026

   Lonza, the world's leading contract development and manufacturing organization (CDMO), and Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, announced today a strategic collaboration to advance lentiviral vector (LVV) manufacturing for emerging in vivo applications. 

8. Future Fields Closes Oversubscribed $8M Series A to Turn Flies Into Bioreactors That Address Undruggable Diseases 9/26/2026
9. INFORS HT Launches Multifors 3 Bench-Top Bioreactor For Process Development 9/24/2026

   Multifors 3 is what bench-scale parallel bioprocessing should look like in 2026. It's built around a simple idea: the bioreactor should capture and retain the information that matters, so scientists can focus on their process. PID settings, cascades, hardware configuration, and sensor metadata are documented automatically, helping teams reproduce the complete process configuration.

10. Andelyn Biosciences To Implement Curator® Platform To Develop And Manufacture Gene Therapy AAV9-GM2 For Queen's University To Treat GM2 Gangliosidoses 9/21/2026

    Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy candidate for the treatment of GM2 gangliosidoses, such as Tay-Sachs and Sandhoff diseases.